ClearBridge Investments’s Pfizer PFE Stock Holding History

ClearBridge Investments’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.04M	Sell	43,369 -3,546	-8%	-$92.8K	﹤0.01%	631
2026 Q1	$1.32M	Sell	46,915 -2,484	-5%	-$66.1K	﹤0.01%	615
2025 Q4	$1.23M	Sell	49,399 -1,471	-3%	-$37.1K	﹤0.01%	633
2025 Q3	$1.3M	Sell	50,870 -13,828	-21%	-$341K	﹤0.01%	646
2025 Q2	$1.57M	Sell	64,698 -6,345	-9%	-$148K	﹤0.01%	623
2025 Q1	$1.8M	Sell	71,043 -60,101	-46%	-$1.57M	﹤0.01%	616
2024 Q4	$3.46M	Sell	131,144 -71,176	-35%	-$1.93M	﹤0.01%	595
2024 Q3	$5.86M	Sell	202,320 -408,279	-67%	-$11.9M	﹤0.01%	571
2024 Q2	$17.1M	Sell	610,599 -22,361	-4%	-$616K	0.01%	466
2024 Q1	$17.6M	Sell	632,960 -7,101,709	-92%	-$197M	0.01%	478
2023 Q4	$223M	Sell	7,734,669 -1,850,411	-19%	-$55.9M	0.19%	129
2023 Q3	$318M	Sell	9,585,080 -2,190,344	-19%	-$77.5M	0.31%	88
2023 Q2	$432M	Sell	11,775,424 -524,885	-4%	-$20.4M	0.39%	75
2023 Q1	$502M	Sell	12,300,309 -1,620,429	-12%	-$70M	0.48%	59
2022 Q4	$713M	Sell	13,920,738 -395,037	-3%	-$18.9M	0.7%	33
2022 Q3	$626M	Sell	14,315,775 -76,630	-0.5%	-$3.72M	0.63%	36
2022 Q2	$755M	Buy	14,392,405 +2,072,665	+17%	+$106M	0.7%	28
2022 Q1	$638M	Buy	12,319,740 +151,311	+1%	+$7.85M	0.48%	57
2021 Q4	$719M	Sell	12,168,429 -32,873	-0.3%	-$1.63M	0.49%	50
2021 Q3	$525M	Buy	12,201,302 +86,436	+0.7%	+$3.83M	0.37%	73
2021 Q2	$474M	Sell	12,114,866 -363,652	-3%	-$14.1M	0.33%	76
2021 Q1	$452M	Sell	12,478,518 -189,069	-1%	-$6.71M	0.34%	77
2020 Q4	$466M	Sell	12,667,587 -2,570,627	-17%	-$94.3M	0.36%	69
2020 Q3	$531M	Sell	15,238,214 -621,238	-4%	-$21.8M	0.46%	59
2020 Q2	$492M	Buy	15,859,452 +256,459	+2%	+$8.71M	0.44%	61
2020 Q1	$483M	Buy	15,602,993 +2,120,052	+16%	+$72.2M	0.52%	55
2019 Q4	$501M	Buy	13,482,941 +39,404	+0.3%	+$1.4M	0.41%	70
2019 Q3	$458M	Buy	13,443,537 +327,548	+2%	+$11.9M	0.4%	73
2019 Q2	$539M	Sell	13,115,989 -105,281	-0.8%	-$4.18M	0.47%	67
2019 Q1	$533M	Sell	13,221,270 -118,570	-0.9%	-$4.75M	0.47%	65
2018 Q4	$552M	Buy	13,339,840 +735,721	+6%	+$30.5M	0.56%	46
2018 Q3	$527M	Buy	12,604,119 +780,232	+7%	+$30M	0.45%	64
2018 Q2	$407M	Sell	11,823,887 -197,064	-2%	-$6.73M	0.33%	94
2018 Q1	$405M	Sell	12,020,951 -80,654	-0.7%	-$2.77M	0.38%	84
2017 Q4	$416M	Sell	12,101,605 -58,853	-0.5%	-$2.01M	0.38%	84
2017 Q3	$412M	Buy	12,160,458 +579,220	+5%	+$18.6M	0.4%	77
2017 Q2	$369M	Buy	11,581,238 +76,963	+0.7%	+$2.43M	0.36%	81
2017 Q1	$373M	Buy	11,504,275 +56,996	+0.5%	+$1.8M	0.38%	75
2016 Q4	$353M	Sell	11,447,279 -118,650	-1%	-$3.62M	0.39%	75
2016 Q3	$372M	Sell	11,565,929 -797,463	-6%	-$26.7M	0.42%	65
2016 Q2	$413M	Buy	12,363,392 +5,148	+0%	+$164K	0.49%	62
2016 Q1	$348M	Buy	12,358,244 +2,554,510	+26%	+$73M	0.42%	66
2015 Q4	$300M	Buy	9,803,734 +1,617,959	+20%	+$50.9M	0.35%	84
2015 Q3	$244M	Sell	8,185,775 -169,132	-2%	-$5.42M	0.29%	97
2015 Q2	$266M	Sell	8,354,907 -208,944	-2%	-$6.81M	0.28%	101
2015 Q1	$283M	Sell	8,563,851 -2,184,431	-20%	-$69.4M	0.29%	97
2014 Q4	$318M	Sell	10,748,282 -875,785	-8%	-$25.1M	0.33%	88
2014 Q3	$326M	Sell	11,624,067 -5,833,051	-33%	-$164M	0.36%	83
2014 Q2	$492M	Sell	17,457,118 -648,449	-4%	-$18.5M	0.55%	46
2014 Q1	$552M	Buy	18,105,567 +132,810	+0.7%	+$3.96M	0.65%	34
2013 Q4	$522M	Sell	17,972,757 -23,663	-0.1%	-$689K	0.65%	35
2013 Q3	$490M	Buy	17,996,420 +545,116	+3%	+$14.8M	0.68%	31
2013 Q2	$464M	Buy	+17,451,304	New	+$482M	0.71%	28

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

ClearBridge Investments's PFE Position: Q2 2026 in Review

ClearBridge Investments reduced its Pfizer (PFE) stake by 7.6% in Q2 2026, selling an estimated $92.8K and leaving 43,369 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #631.

ClearBridge Investments first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $755M in Q2 2022. 2,429 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

ClearBridge Investments held 43,369 shares of Pfizer worth $1.04M as of Q2 2026.
ClearBridge Investments sold 3,546 Pfizer shares in Q2 2026, an estimated $92.8K.
Pfizer made up ﹤0.01% of ClearBridge Investments's portfolio in Q2 2026, its #631 holding.
ClearBridge Investments first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
ClearBridge Investments's Pfizer position peaked at $755M in Q2 2022.
2,429 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on ClearBridge Investments's 13F filing for Q2 2026, filed 13 Aug 2026.